Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Celltrion
Celltrion
Pfizer Wins Remicade Patent Case Over J&J
RAPS.org
Wed, 08/1/18 - 11:33 pm
Pfizer
Celltrion
JNJ
Janssen
patents
Remicade
Celltrion resubmits Rituxan candidate in US, Herceptin version to follow
Biopharma Reporter
Wed, 05/30/18 - 08:29 pm
Celltrion
Rituxan
biosimilars
FDA
Herceptin
Roche
Biogen
CT-P10
Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe
CP Wire
Thu, 05/3/18 - 09:33 am
Herzuma
biosimilars
trastuzumab
Europe
Herceptin
Roche
Mundipharma
Celltrion
Will Teva's Fremanezumab Be Delayed due to Troubles at Celltrion?
Market Realist
Mon, 03/26/18 - 09:43 am
Teva Pharmaceutical
fremanezumab
Celltrion
migraines
Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar
JD Supra
Thu, 12/7/17 - 09:07 am
Pfizer
JNJ
Remicade
biosimilars
anticompetitive practices
Celltrion
FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
RAPS.org
Fri, 09/8/17 - 09:28 am
FDA
Celltrion
biosimilars
Pfizer
Inflectra
Remicade
As Roche wades biosimilar waters, more competitors circle Herceptin
BioPharma Dive
Wed, 08/2/17 - 09:28 pm
Roche
Herceptin
biosimilars
Amgen
Allergan
ABP 980
Celltrion
CT-P6
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Fierce Pharma
Mon, 07/31/17 - 09:56 pm
FDA
Herceptin
biosimilars
Roche
Amgen
Teva Pharmaceutical
Allergan
Celltrion
Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug
Xtalks
Mon, 02/27/17 - 10:02 pm
Pfizer
Celltrion
biosimilars
Crohn's Disease
Inflectra
Remicade
Pfizer, Celltrion pushing for interchangeability with Inflectra
BioPharma Dive
Thu, 02/23/17 - 09:11 am
Pfizer
Celltrion
Inflectra
JNJ
biosimilars
Remicade
Teva ponies up $160M-plus for marketing rights to Celltrion's Rituxan, Herceptin biosims
Fierce Pharma
Fri, 10/7/16 - 09:11 am
Teva Pharmaceutical
Celltrion
Rituxan
Herceptin
biosimilars
J&J Remicade Patent Found Invalid in U.S. Victory for Pfizer
Bloomberg
Thu, 08/18/16 - 04:13 pm
Pfizer
JNJ
Remicade
biosimilars
Inflectra
Celltrion
Hospira
Will the approval of Inflectra be a biosimilar adoption tipping point?
BioPharma Dive
Fri, 06/10/16 - 10:18 am
Inflectra
biosimilars
Celltrion
Remicade
JNJ
rheumatoid arthritis
FDA Licenses a Second Biosimilar – The Parameters of Approval Come Into Better Focus
FDA Law Blog
Thu, 04/7/16 - 09:49 am
FDA
biosimilars
JNJ
Remicade
Inflectra
Pfizer
Celltrion
FDA approves 1st cheaper version of J&J's top drug Remicade
Yahoo/AP
Tue, 04/5/16 - 10:16 pm
FDA
Remicade
JNJ
Inflectra
biosimilars
Celltrion
Pfizer
Switching study gives Celltrion biosim more ammo in fight for Remicade share
Fierce Pharma Marketing
Tue, 03/22/16 - 09:54 am
Celltrion
biosimilars
Merck
Remicade
Remsima
Can Pharma Learn to Stop Worrying and Love Biosimilars?
Forbes
Thu, 02/11/16 - 08:28 am
biosimilars
Novartis
Celltrion
Pfizer
Zarxio
CT-P13
Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications
Yahoo
Wed, 02/10/16 - 09:37 am
FDA
Pfizer
advisory panels
biosimilars
infliximab
Celltrion
FDA panel backs Pfizer and Celltrion's Remicade biosimilar over J&J's objections
Fierce Biotech
Tue, 02/9/16 - 05:35 pm
FDA
advisory panels
Pfizer
Celltrion
Remicade
JNJ
biosimilars
FDA reviewers support Celltrion's biosimilar Remicade
Yahoo/Reuters
Fri, 02/5/16 - 09:21 am
FDA
Celltrion
biosimilars
Remicade
arthritis
Remsima
JNJ
Pfizer
Pages
« first
‹ previous
1
2
3
next ›
last »